ArticleOncology and therapy2024

Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies.

Svenn Alexander Kommandantvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.